RISING PHARMS
GenericsRISING PHARMS is a generic drug manufacturer focused on Respiratory.
RISING PHARMS's Key Drugs
RISING PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
RISING PHARMS's Recent FDA Approvals
New NDA/BLA approvals for RISING PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
RISING PHARMS's Therapeutic Areas
RISING PHARMS's approved drugs and pipeline span 1 therapeutic area, led by Respiratory. Weighted by commercial stage — approved drugs count most, then late-stage trials.
RISING PHARMS's Top Competitors
RISING PHARMS's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and GSK. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
RISING PHARMS Pipeline Snapshot
Active clinical trials for RISING PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Respiratory pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2022-08-25
- Latest
- 2022-08-25
- Applications
- 1